| abstract |
The immunoconjugate contains a monoclonal antibody or a fragment thereof selected from the group consisting of Fv, Fab, F (ab '). Sub.2.n. and CH3 and CH2, targeting the either the antigen epitope epidermal epitope epitope (EGFR) and the chemokine protein that is fused to the antibody or to the antibody fragment induces cytotoxic and chemotactic activity and is suitable pro - duced therapy. \ t |